Healthcare Market Research That Survives the Formulary Committee

We interview 15-20 formulary directors, former HTA committee members, and payer decision-makers per market. The output is a gap analysis mapping your current evidence package against the specific pharmacoeconomic and clinical endpoints each jurisdiction requires for positive coverage.

Formative and summative human factors research with clinical end-users in their procedural environments. Surgeons, nurses, and technicians test devices under actual operating conditions. Findings are structured for FDA and notified body submission packages.

Multi-week behavioral studies that track where patients drop off therapy: step-therapy insurance barriers, caregiver logistics, portal fatigue, PBM-driven substitutions. Recruited through clinical sites, specialty pharmacies, and patient advocacy networks. Longitudinal data, not single-visit self-reports.

We map Key Opinion Leader influence through referral network analysis and clinical practice pattern research, not publication counts. Structured expert interviews capture which data changes prescribing, which peer recommendations carry weight, and which treatment guidelines physicians actually follow in oncology, immunology, CNS, and rare disease.